Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109351) titled 'Skin Sensitization Activity of BTM Multiple Skin Care Products' on April 24.

Study Type: Interventional

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: BTM Ventures Pvt

Intervention: Intervention1: Finn Chamber: Each Patch contain 0.04ml/(40 microgram) of test sample,1.Vitamin C face Serum 2.Niacinamide face Serum 3.Vitamin C facewash 4.Niacinamide Face Wash, Administration: Topical Frequency: every second day- as per BIS 4011 Duration: 41 days Control Intervention1:...